An interventional study of Education and message in Copd and Fatigue, sponsored by Kirsehir Ahi Evran Universitesi. Recruiting at 1 site in Turkey. Open to participants aged 18 Years to 85 Years. Per ClinicalTrials.gov, last updated 2024-08-07.
Sponsored by Kirsehir Ahi Evran Universitesi · Not applicable, Interventional, and Supportive care
COPD is an important respiratory system disease that progresses with damage to the airways.Increased mucus secretion and thickening in the airways causes obstruction.This obstruction causes symptoms such as shortness of breath, cough, phlegm and wheezing.The most obvious problem that the emerging symptoms will cause for the patient is fatigue.Coping with fatigue is an important problem in COPD.
The main questions it aims to answer are:
In this study, patients were given informative education about COPD and ways to cope with fatigue were explained. Then, in order to increase the permanence of the training, motivational messages and short briefings were continued for 8 weeks.2 messages were sent per week. Three groups were created to reveal the effectiveness of the trainings and messages.
Group 1 was trained and messages were sent for 8 weeks. Group 2 was trained and no message was sent. Group 3 is the control group. No training has been provided other than routine maintenance.
The initial information of all groups was taken again at the end of the 8th week.
Main outcomes:
1,860 studies on the registry are indexed under Fatigue; 376 are open to participants now.
This study's planned enrollment of 120 is above the median of 54 across 1,440 interventional studies indexed under Fatigue.
Browse Fatigue studies →Kirsehir Ahi Evran Universitesi is the lead sponsor of 133 studies on the registry; 55 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Patients in this group were given training for 3 consecutive days during their stay in the hospital. Day 1: general information about the disease, medication use Day 2: Physiology of fatigue, factors causing fatigue, and the relationship between COPD and fatigue. Day 3 Strategies to cope with fatigue (Breathing exercises, good thinking, etc.) Patients were messaged twice a week after they were discharged. Message sent for 8 weeks. Short, motivating and reminder messages were used. For example; * When I can control my shortness of breath, my fatigue level decreases significantly. * Excessive thinking and stress lead to more fatigue. That's why I stay away from negative thoughts. At the baseline and 8th weeks, the patients were interviewed again and their dyspnea and fatigue levels were measured again.
Other: Education and message
Patients in this group were given training for 3 consecutive days during their stay in the hospital. Day 1: general information about the disease, medication use Day 2: Physiology of fatigue, factors causing fatigue, and the relationship between COPD and fatigue. Day 3 Strategies to cope with fatigue (Breathing exercises, good thinking, etc.) No other treatment was performed on these patients. At the baseline and end of 8 weeks, the patients were interviewed again and their dyspnea and fatigue levels were measured again.
Other: Education and message
These patients received routine treatment and care in the clinic. No training was given. Message not sent. At the baseline and 8th weeks, the patients were interviewed again and their dyspnea and fatigue levels were measured again.
Other: Education and message
COPD general education content and fatigue-specific coping strategies. Messages sent to phones
Fatigue Level
Evaluated with COPD ASTHMA FATIGUE SCALE.
Time frame: Applied at baseline and after 8 weeks.
Dyspnea Severity
Evaluated with mMRC Dyspnea Scale
Time frame: Applied at baseline and after 8 weeks.
COPD general condition
Evaluated with COPD ASSESSMENT QUESTIONNAIRE (CAT)
Time frame: Applied at baseline and after 8 weeks.
Plan to share: No
No publications or documents are linked to this record.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Kirsehir Ahi Evran Universitesi